Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 93
Filter
1.
Health Inf Manag ; : 18333583231188396, 2023 Aug 31.
Article in English | MEDLINE | ID: mdl-37653585

ABSTRACT

Background: Lymphoedema is a condition of localised swelling caused by a compromised lymphatic system. The protein-rich fluid accumulating in the interstitial tissue can create inflammation and irreversible changes to the skin and underlying tissue. An array of methods has been used to assess and report these changes. Heterogeneity is evident in the clinic and in the literature for the domains assessed, outcomes and outcome measures selected, measurement protocols followed, methods of analysis, and descriptors used to report change. Objective: This study seeks consensus on the required items for inclusion in a core data set for upper limb lymphoedema to digitise the monitoring and reporting of upper limb lymphoedema. Methods: The breadth of outcomes and descriptors in common use were captured in prior studies by this research group. This list was refined by frequency and proposed to experts in the field (n = 70) through a two-round online modified Delphi study. These participants rated the importance of each item for inclusion in the dataset and identified outcomes or descriptors they felt were missing in Round 1. In Round 2, participants rated any new outcomes or descriptors proposed and preference for how numeric data is displayed. Results: The core dataset was confirmed on completion of Round 2. Interlimb difference as a percentage, and limb volume were preferred for graphed display over time; and descriptors for observed and palpated change narrowed from 42 to 20. Conclusion: This dataset provides the foundation to create a clinical support system for upper limb lymphoedema.

2.
Lymphat Res Biol ; 21(3): 296-303, 2023 06.
Article in English | MEDLINE | ID: mdl-36154463

ABSTRACT

Background: Breast lymphedema after breast cancer is challenging to quantify. Three-dimensional (3D) surface imaging is one available technique to measure breast volume, however, the measurement properties of available software programs have not been fully determined. The aim of this study was to determine equivalency of measurements with two software programs as well as reliability, standard error of measurement (SEM), and smallest detectable change (SDC). Methods and Results: Retrospective three-dimensional surface imaging (3D-SI) of 100 breasts taken before or after breast conserving surgery for breast cancer were retrieved for reliability analysis. Three assessors followed a standardized measurement technique using two software programs, Vectra® 3D Analysis Module (VAM) and Breast Sculptor®. Mean breast volume was 489.9 ± 206 cc using VAM and 480.1 ± 229.1 cc using Breast Sculptor. Lin's concordance showed poor agreement between programs (0.81-0.88). Measurements using VAM had excellent intra- and inter-rater reliability with SEM = 4.1% for one assessor and 8.7% for multiple assessors. Breast Sculptor also had excellent intra-rater and substantial inter-rater reliability but the SEM was much larger at 14.5% (intra-rater) and 19.1% (inter-rater). The SDC value was lowest for VAM and a single rater with 56 cc indicating a meaningful change beyond measurement error. Conclusion: Breast volume measurements captured with 3D-SI using VECTRA-XT are highly reliable, but the volumes, SEM, and SDC varied between the two software programs. Measurement error was lowest with VAM software. Although the usefulness of VECTRA-XT and VAM software to detect change in breast volume is promising, further solutions to reduce measurement error are required to improve clinical utility to measure breast lymphedema.


Subject(s)
Breast Neoplasms , Lymphedema , Humans , Female , Reproducibility of Results , Retrospective Studies , Imaging, Three-Dimensional/methods , Breast Neoplasms/complications , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/surgery , Lymphedema/diagnosis
3.
J Cancer Surviv ; 17(6): 1669-1687, 2023 12.
Article in English | MEDLINE | ID: mdl-36301407

ABSTRACT

PURPOSE: Breast lymphoedema is a possible side effect of breast conserving surgery, but it is poorly understood. This is due, in part, to difficulty assessing the breast. This systematic review described outcome measures that quantify breast lymphoedema signs and symptoms and evaluated the measurement properties for these outcome measures. METHOD: Seven databases were searched using terms in four categories: breast cancer, lymphoedema and oedema, clinician reported (ClinROM) and patient reported outcome measures (PROM) and psychometric and measurement properties. Two reviewers independently reviewed studies and completed quality assessments. The Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) methodology was used for studies including measurement property evidence. RESULTS: Fifty-six papers were included with thirteen questionnaires, eight patient-reported rating scales, seven physical measures, seven clinician-rating scales and four imaging techniques used to quantify breast lymphoedema. Based on COSMIN methodology, one ClinROM had sufficient reliability, ultrasound measuring dermal thickness. Tissue dielectric constant (TDC) measuring local tissue water had promising reliability. Four questionnaires had sufficient content validity (BLYSS, BLSQ, BrEQ and LYMQOL-Breast). CONCLUSIONS: Ultrasound is recommended to reliably assess breast lymphoedema signs. No PROM can be recommended with confidence, but BLYSS, BLSQ, BrEQ and LYMQOL-Breast are promising. Further research is recommended to improve evidence of measurement properties for outcome measures. IMPLICATIONS FOR CANCER SURVIVORS: There are many approaches to assess breast lymphoedema, but currently, only ultrasound can be recommended for use, with others, such as TDC and questionnaires, showing promise. Further research is required for all approaches to improve evidence of measurement properties.


Subject(s)
Breast Neoplasms , Cancer Survivors , Lymphedema , Humans , Female , Breast Neoplasms/surgery , Reproducibility of Results , Patient Reported Outcome Measures , Lymphedema/diagnosis , Lymphedema/etiology , Psychometrics/methods
4.
Lymphat Res Biol ; 21(2): 152-159, 2023 04.
Article in English | MEDLINE | ID: mdl-35877387

ABSTRACT

Background: The safety and feasibility of using kinesiotape as a short-term alternative treatment to compression garments or gloves for hand lymphedema have not been examined. The aim of this study was to examine if kinesiotape could maintain size and extracellular fluid (ECF) volume of the hand and forearm, as well as upper limb function and quality of life for women with secondary hand lymphedema. Methods and Results: Six women with secondary hand lymphedema underwent pretreatment measurements, including hand and digit size using a tape measure; ECF volume using bioimpedance spectroscopy; and patient-reported outcome measurements of upper limb function and quality of life. Kinesiotape was then applied to the dorsum of the hand and left for 48 h, during which participants were asked not to wear compression garments. Posttreatment measurements were completed after kinesiotape removal. Changes in measurements were compared to the smallest detectable change (SDC). Hand size did not change more than the SDC; however, a single affected digit increased in circumference by more than the SDC. Changes of the whole arm ECF volume were less than the SDC. The ECF volume of the dorsum of the hand increased in one and decreased in another participant. The forearm ECF volume decreased in two participants. Upper limb function and quality of life did not change. No adverse event was reported. Conclusion: Short-term kinesiotape use appears to be safe in maintaining the physical presentation of hand lymphedema. However, these results should be examined in a larger sample. The feasibility of using kinesiotape as an alternative treatment to compression requires further investigation. Clinical Trial Registration number: ACTRN12618001232224p, July 23, 2018 retrospectively registered.


Subject(s)
Athletic Tape , Breast Neoplasms , Lymphedema , Humans , Female , Quality of Life , Feasibility Studies , Upper Extremity , Lymphedema/therapy
5.
J Clin Oncol ; 40(18): 2004-2012, 2022 06 20.
Article in English | MEDLINE | ID: mdl-35108031

ABSTRACT

PURPOSE: To determine whether prophylactic use of compression sleeves prevents arm swelling in women who had undergone axillary lymph node dissection for breast cancer surgery. METHODS: Women (n = 307) were randomly assigned to either a compression or control group. In addition to usual postoperative care, the compression group received two compression sleeves to wear postoperatively until 3 months after completing adjuvant treatments. Arm swelling was determined using bioimpedance spectroscopy (BIS) thresholds and relative arm volume increase (RAVI). Incidence and time free from arm swelling were compared using Kaplan-Meier analyses. Hazard ratios (HRs) were estimated from Cox regression models for BIS and RAVI thresholds independently. In addition, time to documentation of the first minimally important difference (MID) in four scales of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the breast cancer-specific (BR23) questionnaire was analyzed. RESULTS: The HR for developing arm swelling in the compression group relative to the control group was 0.61 (95% CI, 0.43 to 0.85; P = .004) on the basis of BIS and 0.56 (95% CI, 0.33 to 0.96; P = .034) on the basis of RAVI. The estimated cumulative incidence of arm swelling at 1 year was lower in the compression group than the control group on the basis of BIS (42% v 52%) and RAVI (14% v 25%). HRs for time from baseline to the first change of the minimally important difference were not statistically significant for any of the four scales of EORTC QLQ-30 and BR23 questionnaires. CONCLUSION: Prophylactic use of compression sleeves compared with the control group reduced and delayed the occurrence of arm swelling in women at high risk for lymphedema in the first year after surgery for breast cancer.


Subject(s)
Breast Cancer Lymphedema , Breast Neoplasms , Lymphedema , Arm/pathology , Breast Cancer Lymphedema/epidemiology , Breast Cancer Lymphedema/etiology , Breast Cancer Lymphedema/prevention & control , Breast Neoplasms/drug therapy , Edema , Female , Humans , Incidence , Lymph Node Excision/adverse effects , Lymphedema/epidemiology , Lymphedema/etiology , Lymphedema/prevention & control , Quality of Life
6.
Support Care Cancer ; 30(5): 3917-3924, 2022 May.
Article in English | MEDLINE | ID: mdl-35039968

ABSTRACT

PURPOSE: (1) To determine, in women with breast cancer-related lymphedema (BCRL), the frequency, intensity and distress of body image and sexuality concerns. (2) To examine relationships between body image and sexuality concerns, and lymphedema, personal and cancer treatment factors. METHOD: Women with BCRL (n = 64) completed the Lymphedema Symptom Intensity and Distress Scale - Arm (LSIDS-A), which focuses on the intensity and distress of a range of lymphedema symptoms. They also underwent a lymphedema assessment. Responses to eight questions from the LSIDS-A regarding sexuality, body image and intimate relationships were considered. Frequency of responses was tabulated. Multiple linear regressions were used to determine if specific factors were related to higher intensity and distress scores associated with body image and sexuality issues. RESULTS: Body image and sexuality concerns were common (48%, 23% respectively). Participants reported a range (0-10) of intensity and distress related to body image and sexuality symptoms. Univariate linear regression revealed greater intensity of sexuality concerns was associated with younger age, whilst distress related to sexuality concerns was associated with higher inter-arm bioimpedance ratio and shorter duration of lymphedema. Body image concerns were not related to any considered factors. CONCLUSION: Body image and sexuality concerns are common, intense and distressing for patients with breast cancer lymphedema. Assessment of both the intensity and distressed caused by these symptoms is necessary to understand the impact of lymphedema.


Subject(s)
Breast Cancer Lymphedema , Breast Neoplasms , Lymphedema , Body Image , Breast Neoplasms/complications , Cross-Sectional Studies , Female , Humans , Lymphedema/diagnosis , Lymphedema/etiology , Sexuality
7.
Lymphat Res Biol ; 20(3): 248-259, 2022 06.
Article in English | MEDLINE | ID: mdl-34748419

ABSTRACT

Background: The impact of conservative interventions on lymphatic function and the relationship to clinical outcomes is currently unknown. A systematic review was undertaken to evaluate studies that used lymphoscintigraphy to measure outcomes from conservative intervention for secondary arm lymphedema and to explore the relationship between changes in the lymphoscintigraphy and clinical outcomes. Methods and Results: Five databases were systematically searched using the selection criteria: randomized controlled trials (RCTs); quasi-RCTs; pre/post and cohort studies; upper limb secondary lymphedema; use of lymphoscintigraphy as an outcome measure; and conservative intervention. Seven articles met the inclusion criteria. Compression, exercise, hyperbaric oxygen therapy, and pharmacological interventions were evaluated using lymphoscintigraphy. There was heterogeneity with all aspects of the lymphoscintigraphy techniques, including radioisotope used, injection location, use of exercise, and imaging sequence between the studies as well as the outcome analysis. Also most studies did not show a relationship between the clinical and lymphoscintigraphy outcomes measured. Conclusions: Lymphoscintigraphy has not been used regularly or recently to evaluate conservative upper limb lymphedema treatment outcomes. Lack of standardization of lymphoscintigraphy protocols and lack of consensus and understanding of the lymphoscintigraphy analyses used to measure the outcomes of diverse conservative lymphedema interventions currently limit the use of lymphoscintigraphy as an outcome measure. Further research adopting recent guidelines to standardize lymphoscintigraphy and use of reliable analysis techniques that measure the physiological impact of the chosen conservative lymphedema intervention is recommended to evaluate the impact of conservative interventions on lymphatic function.


Subject(s)
Lymphatic Vessels , Lymphedema , Humans , Lymphatic System , Lymphedema/diagnostic imaging , Lymphedema/etiology , Lymphedema/therapy , Lymphoscintigraphy , Upper Extremity/diagnostic imaging
8.
Skin Res Technol ; 28(1): 111-118, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34455642

ABSTRACT

BACKGROUND: The current study assessed the level of reliability of ultrasound to assess dermal thickness, a clinical feature of breast lymphedema. Additionally, the relationship of dermal thickness to patient-reported outcomes was investigated. METHODS: Women (n = 82) with unilateral breast edema secondary to treatment of breast cancer were randomized to an exercise or control group. Ultrasound measurements of the unaffected and affected breasts were taken at baseline and 12 weeks later at 3-4 cm superior, medial, inferior, and lateral to the nipple. Additionally, women completed breast-related questions from the European Organization Research and Treatment Committee Quality of Life breast cancer module (EORTC-BR23) and Lymphedema Symptom Intensity and Distress Questionnaire (LSIDS). Reliability of ultrasound measurements was determined on the unaffected breast. RESULTS: Intraclass correlation coefficients (2,1) ranged from 0.66 (95% CI: 0.52-0.77) for the lateral location to 0.84 (0.77-0.90) for the superior location. Percent close agreement (80%) on the unaffected breast ranged from 0.20 to 0.27 mm compared to 0.57 to 0.93 mm on the affected breast. The standard error of measurement (%) on the unaffected breast varied from 9% to 13% with smallest real difference 0.34-0.41 mm. Dermal thickness of the affected breast was not-to-poorly associated with EORTC BR23 and LSIDS scores. CONCLUSION: Reliability of dermal thickness measurements of the breast was excellent for the superior, medial, and inferior locations, and fair to good for the lateral location. However, these measurements were not related to the symptom's women perceive and measured with the EORTC BR23 or LSIDS.


Subject(s)
Breast , Quality of Life , Breast/diagnostic imaging , Female , Humans , Patient Reported Outcome Measures , Reproducibility of Results , Ultrasonography
9.
J Cancer Surviv ; 16(5): 1127-1148, 2022 10.
Article in English | MEDLINE | ID: mdl-34491527

ABSTRACT

PURPOSE: Physical activity is a well-established strategy to alleviate breast cancer-related adverse outcomes. To optimise health benefits, behaviour change theories provide frameworks to support women in improving their physical activity. This review aimed to evaluate (i) the effects of behaviour change theory-based physical activity interventions for women with breast cancer and (ii) the application of these theories. METHODS: Seven online databases were searched. Trials were included if randomised and controlled, involved physical activity interventions ≥ 12 weeks duration, used a behaviour change theory, and participants were < 3 years post-cancer treatment. Risk of bias and theory use were assessed. Data were synthesised narratively and meta-analysed. RESULTS: Forty articles describing 19 trials were included. Overall risk of bias was moderately high. Post-intervention pooled effect estimates were medium for self-reported (SMD = 0.57) and objectively measured physical activity (SMD = 0.52). Most trials cited the social cognitive theory (n = 10) and transtheoretical model (n = 9). Trials rarely applied theories in their entirety, expounded on behavioural mechanisms, or tailored interventions according to behavioural constructs. The most commonly used types of behavioural techniques were goals and planning (n = 18), shaping of knowledge (n = 18), feedback and monitoring (n = 17), and comparisons of outcomes (n = 17). CONCLUSIONS: The included trials were effective for increasing physical activity in women with breast cancer. Theories were applied using a wide range of approaches and levels of rigour, although shared the use of common behavioural techniques. IMPLICATIONS FOR CANCER SURVIVORS: Future research may benefit breast cancer survivors by more comprehensively applying behaviour change theories, emphasising individual patient needs and goals.


Subject(s)
Breast Neoplasms , Cancer Survivors , Breast Neoplasms/therapy , Exercise , Female , Humans , Randomized Controlled Trials as Topic , Survivors
10.
Phlebology ; 36(9): 678-694, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34018859

ABSTRACT

INTRODUCTION: Interface pressure measuring devices are used to assess the pressures exerted by compression. Their performance, however, has not been considered as a contributing factor to reported inconsistences in the application of compression. A systematic review was undertaken to investigate the performance of commercially available devices used to measure interface pressure. METHODS: Six databases were searched identifying 17 devices, grouped into five sensor categories. RESULTS: A range of methodologies assessed the devices' accuracy and precision, including method of pressure application, device calibration and type of surface used. No sensor category outperformed the others, however some individual sensors showed higher accuracy and/or precision compared to others. Two major factors influenced the performance of a number of sensors: the amount of applied pressure and the calibration method used. CONCLUSION: Inconsistences in the application of compression may reflect, in part, issues related to accuracy and precision of the devices used to assess compression.


Subject(s)
Pressure , Calibration , Humans
11.
Acta Oncol ; 60(3): 379-391, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33475033

ABSTRACT

INTRODUCTION: Lymphoedema may develop as a result of numerous genetic and traumatic causes; however, treatment for cancer is the most common cause of its development in more economically developed nations. This systematic review critically appraised, compared and summarised the measurement properties of lymphoedema-specific self-reported questionnaires (SRQs) measuring various patient-reported outcomes including quality of life (QOL), function, morbidity, and symptoms. METHODS: Seven databases were searched to identify studies of the measurement properties of SRQs. Two review teams independently evaluated the quality of the individual studies using the risk of bias tool from the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN). Measurement properties of the SRQs presented in the studies were then rated. Study level ratings were summarised for an SRQ if they were reported in multiple studies, and their overall quality of the evidence were then graded. RESULTS: Forty articles, reporting on 19 SRQs were identified from 8615 records. The focus of the 19 SRQs included eight on QOL, four on symptoms, two on function, and two on impairment. The other three SRQs were on illness perception, self-efficacy, and patient-relevant treatment benefit, respectively. Eight and three SRQs were upper limb and lower limb-specific, respectively, whereas seven questionnaires were for both upper and lower limb lymphoedema. One SRQ was developed for head and neck lymphoedema. According to the COSMIN framework, none of the SRQs reviewed had sufficient evidence to support all nine measurement properties. In lower limb questionnaires, the LYMQOL-leg has sufficient content, structural, and construct validity as well as internal consistency and reliability. For upper limb lymphoedema questionnaires, the Lymph-ICF-UL had sufficient content and construct validity as well as reliability. CONCLUSION: LYMQOL-leg SRQ is recommended with confidence for evaluation of QOL of people with lower limb lymphoedema while the Lymph-ICF-UL is recommended for evaluation of the QOL of the breast cancer-related lymphoedema with some confidence. In view of the high level of the indeterminate ratings of the measurement properties of the existing SRQs, further research is desirable.


Subject(s)
Lymphedema , Quality of Life , Humans , Lymphedema/diagnosis , Lymphedema/etiology , Reproducibility of Results , Self Report , Surveys and Questionnaires
12.
Phys Ther ; 101(2)2021 02 04.
Article in English | MEDLINE | ID: mdl-33313914

ABSTRACT

OBJECTIVE: Hand swelling may result from injury or trauma. Various physical assessment tools and measurement methods can be used to quantify the volume or size of the hand or fingers; however, the reliability and validity of each tool and measurement method have not been evaluated. The purpose of this study was to evaluate the reliability and validity of physical assessment tools and methods used to quantify hand and finger volume orsize. METHODS: MEDLINE, CINAHL, EMBASE, Web of Science, and Scopus were searched using key terms related to swelling, edema, volume, size, hand, measures, reliability, and validity. Cross-sectional or longitudinal studies that assessed reliability and/or validity of physical assessment tools or measurement methods to quantify hand swelling were included. Two examiners independently extracted data from the included articles and appraised the articles' quality using the Consensus-Based Standards for the Selection of Health Measurement Instruments methodology. Data extracted from studies analyzing reliability and validity were grouped by type of assessment tool and measurement method. RESULTS: Five physical assessment tools used for quantification of hand swelling were evaluated, including tape measure, water volumeter, bioimpedance spectroscopy, ring gauge, 3-dimensional techniques. All assessment tools had good to excellent reliability (ICC = 0.74 - 0.99), and moderate to high validity (Pearson coefficient = 0.58 - 0.99), for quantification of the volume or size of the hand or fingers. CONCLUSION: All measurement methods with these tools had good to excellent reliability and moderate to high validity. The evidence underpinning the figure-of-eight technique, which uses a tape measure, was the highest. Because these physical assessment tools and measurement methods assess different aspects and regions of the hand, which one is selected depends on the region of interest for assessment and the availability of tools. IMPACT: Reliable tools and measurement methods are available to measure the size or volume of the hand and fingers, either together or separately. The best tool will depend on the aim of assessment and tool availability. LAY SUMMARY: Hand swelling can occur with injuries, burns, or lymphedema. This review shows that tools are available to accurately measure swelling in any part of thehand.


Subject(s)
Body Weights and Measures/standards , Edema/physiopathology , Hand/physiopathology , Humans , Reproducibility of Results
13.
Lymphat Res Biol ; 19(2): 181-188, 2021 04.
Article in English | MEDLINE | ID: mdl-32986508

ABSTRACT

Background: Bioimpedance spectroscopy (BIS) devices are routinely used in the assessment of breast cancer-related lymphedema (BCRL). The equipotential electrode placement is a commonly used protocol for the assessment of BCRL. However, the sternal notch electrode placement protocol is also in use. Whether these two protocols are interchangeable is not known. Methods and Results: Ethical approval was received from the institutional ethics committee at Tata Memorial Hospital, India. BIS measurements (whole-body right side and affected and unaffected arms) of 100 women with or at risk of BCRL were measured using equipotential and sternal notch protocols. Resistance at zero frequency (R0) was determined, and agreement of the absolute R0 values and the R0 ratio (unaffected/affected) between protocols was evaluated (Bland-Altman analysis and Passing-Bablok regression analysis). Mean absolute differences between protocols were very small for whole-body right side, affected arm, unaffected arm, and the interarm ratio at 0.23 ohms (95% confidence interval [CI]: -3.8 to 4.3), -5.7 ohms (95% CI: -7.5 to -3.9), -9.09 ohms (95% CI: -11.4 to -6.8), and -0.008 ohms (95% CI: -0.02 to 0.001), respectively. Limits of agreement (two standard deviation) between protocols were narrow for whole-body right side, affected arm, unaffected arm, and interarm ratio without any systematic or proportional differences for whole-body right side and the interarm ratio (5.8% to -5.6%, 3.7% to -7.4%, 3.5% to -8.2%, and 5.8% to -5.6%, respectively). Conclusion: The equipotential and sternal notch protocols could be used interchangeably in BCRL assessment. The Clinical Trial Registration number: CTRI/2017/12/010762.


Subject(s)
Breast Cancer Lymphedema , Breast Neoplasms , Lymphedema , Breast Neoplasms/complications , Electrodes , Female , Humans , India , Lymphedema/diagnostic imaging , Lymphedema/etiology , Spectrum Analysis
14.
Lymphat Res Biol ; 19(2): 159-164, 2021 04.
Article in English | MEDLINE | ID: mdl-32986511

ABSTRACT

Background: Clinical management of lymphedema requires assessment, initially for detection, and then for determining treatment response and informing the treatment plan. It is unknown how the components of a lymphedema assessment are used in a clinical environment. Methods and Results: Experienced lymphedema therapists were observed assessing patients presenting with new or existing upper body lymphedema. Occupational and physiotherapists specializing in lymphedema management (n = 14) from public and private, rural and urban settings in Australia were visited at their work sites and observed with a minimum of two patients. In total, 37 upper limb assessments were observed. Reasons for attendance included: initial assessment with new swelling (n = 4); screening/detection for possible lymphedema (n = 3); bandaging as part of an intensive treatment program (n = 2); and review (n = 28). Clinicians were observed, in order of frequency, using (1) patient-reported outcomes, (2) palpation, (3) visual assessment, (4) assessment of limb size using circumference measurements, and (5) assessment of extracellular fluid using bioimpedance spectroscopy. Although clinicians selected similar assessments, differences were observed in the measurement protocols and informed reported. Objective assessment was commonly absent when the time available for an appointment was 30 minutes. Conclusions: While clinicians spent a significant portion of an appointment time assessing the limb, a standardized approach to the assessment of lymphedema was not observed. In the absence of a standardized assessment set, therapists have developed bespoke assessment routines.


Subject(s)
Lymphedema , Australia , Breast Neoplasms , Female , Humans , Upper Extremity
15.
Lymphat Res Biol ; 19(2): 151-158, 2021 04.
Article in English | MEDLINE | ID: mdl-32808861

ABSTRACT

Background: A variety of objective and subjective assessments are available for clinical assessment of lymphedema. The aim of this study was to explore the clinical reasoning underpinning the assessment of upper limb lymphedema by experienced lymphedema clinicians. Methods and Results: Semistructured, individual, interviews were conducted with lymphedema therapists (n = 14) from a variety of treatment settings. These interviews were conducted after observations of these therapists assessing patients with lymphedema and focused on: (1) the therapists' rationale for the assessments selected, (2) how the data were analyzed, and (3) how the information was then used. Assessment selection was guided by the purpose of the visit, patient preference, resources, and time available. Subjective measures of visible and palpated tissue changes were used to target treatment, and objective measures of circumference and bioimpedance spectroscopy and patient report of symptoms informed treatment evaluation and disease progression. Objective data collected were primarily analyzed for interlimb difference and change between appointments. Conclusions: A range of clinical assessments were used in the evaluation of lymphedema to detect the presence of lymphedema, estimate the extent of soft tissue change, understand the patient experience of lymphedema, and evaluate treatment response. A primary determinant for the collection of objective measures was the appointment duration. Current methods of data analysis and reporting do not facilitate the review of change over time.


Subject(s)
Lymphedema , Breast Neoplasms , Clinical Reasoning , Female , Humans , Upper Extremity
16.
Lymphat Res Biol ; 18(5): 448-454, 2020 10.
Article in English | MEDLINE | ID: mdl-32069138

ABSTRACT

Background: Bioimpedance spectroscopy (BIS) measurements of breast lymphedema poses practical and technical challenges, in particular the determination of the resistance at zero frequency (R0), the index of change in breast lymph content. Conventionally, R0 is calculated from data analysis by using a procedure eponymously known as Cole modeling, a method that is error-prone in the breast. The aim of this study was to evaluate polynomial curve fitting as an alternative analytic procedure. Methods and Results: A sub-set of breast BIS measurements from 41 women with self-ascribed breast lymphedema obtained as part of the Breast Edema Exercise Trial (BEET) were analyzed by both the Cole and polynomial methods. BIS files for all subjects were able to be analyzed by using the polynomial method but only 73% and 88% of data files were analyzed for the affected and unaffected breasts, respectively, by using the Cole method. For those files that were capable of being analyzed by both methods, R0 values were highly correlated (r = 0.99) but with a small (1.6%) although statistically significant difference (paired t test, p < 0.001) between methods. Conclusions: Analysis of BIS data using polynomial curve fitting is an acceptable and robust alternative to Cole modeling, particularly where impedance measurements are susceptible to technical sources of error of measurement. The small magnitude of difference observed between methods is unlikely to lead to misclassification of patients with lymphedema based on BIS assessment.


Subject(s)
Lymphedema , Breast Neoplasms , Dielectric Spectroscopy , Electric Impedance , Female , Humans
17.
Support Care Cancer ; 28(7): 3073-3080, 2020 Jul.
Article in English | MEDLINE | ID: mdl-31641870

ABSTRACT

INTRODUCTION: In the absence of monitoring programs, those at risk of developing breast cancer-related lymphoedema (BCRL) must detect its development. However, the efficacy of self-assessment for BCRL has not been widely investigated. This study will determine if symptoms and signs of BCRL are associated with lymphoedema detected by bioimpedance spectroscopy (BIS) and whether those with and without BCRL can accurately assess the signs of its presence. METHODS AND RESULTS: Participants with a history of breast cancer (n = 100) reported the presence/absence of symptoms associated with upper limb BCRL and underwent assessment for pitting oedema and differences in tissue texture between their arms (pinch). BIS detected BCRL in 48 women. Women were more likely to have BIS-detected BCRL if they reported swelling (odds ratio (OR), 58.8; 95% CI, 4.9 to 709.4; p = 0.001) or had inter-limb tissue texture differences in their forearm (OR, 73.5; 95% CI, 7.3 to 736.9; p = < 0.001) or upper arm (OR, 23.9; 95% CI, 2.8 to 201.7; p = 0.003). Agreement between therapist and self-assessment of signs of BCRL was almost perfect (kappa, 0.819 to 0.940). A combination of self-reported swelling and/or self-assessed forearm tissue texture difference identified all cases of BIS-detected BCRL. CONCLUSION: Participants accurately identified the presence or absence of physical signs of BCRL in their arm. Perceived swelling and differences in tissue texture in the affected arm were associated with, and sensitive to, BIS-detected BCRL. These findings support the use of self-assessment to determine if BCRL is developing, indicating the need for professional assessment.


Subject(s)
Breast Cancer Lymphedema/diagnosis , Self-Assessment , Adult , Aged , Aged, 80 and over , Arm/pathology , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Early Detection of Cancer , Female , Humans , Middle Aged , Self Report
18.
J Pain Symptom Manage ; 58(6): 929-939, 2019 12.
Article in English | MEDLINE | ID: mdl-31374368

ABSTRACT

CONTEXT: Physical activity for women with early-stage breast cancer is well recognized for managing cancer-related symptoms and improving quality of life. While typically excluded from interventions, women with metastatic breast cancer may also benefit from physical activity. OBJECTIVE: To 1) determine the safety and feasibility of a physical activity program for women with metastatic breast cancer and 2) explore the efficacy of the program. METHODS: Fourteen women with metastatic breast cancer were randomized to either a control group or an 8-week home-based physical activity intervention comprising twice weekly supervised resistance training and an unsupervized walking program. RESULTS: The recruitment rate was 93%. Adherence to the resistance and walking components of the program was 100% and 25%, respectively. No adverse events were reported. When mean change scores from baseline to postintervention were compared, trends in favor of the exercise group over the control group were observed for the Functional Assessment of Chronic Illness Therapy-Fatigue score (+5.6 ± 3.2 vs. -1.8 ± 3.9, respectively), VO2max (+1.6 ml/kg/minute ±1.8 mL/kg/minute vs. -0.2 mL/kg/minute ±0.1 mL/kg/minute, respectively) and six-minute walk test (+40 m ± 23 m vs. -46 m ± 56 m, respectively). CONCLUSION: A partially supervised home-based physical activity program for women with metastatic breast cancer is feasible and safe. The dose of the resistance training component was well tolerated and achievable in this population. In contrast, adherence and compliance to the walking program were poor. Preliminary data suggest a physical activity program, comprising predominantly resistance training, may lead to improvements in physical capacity and may help women to live well with their disease.


Subject(s)
Breast Neoplasms/therapy , Exercise Therapy/methods , Exercise , Adult , Aged , Anaerobic Threshold , Breast Neoplasms/complications , Fatigue/etiology , Fatigue/prevention & control , Feasibility Studies , Female , Home Care Services , Humans , Middle Aged , Neoplasm Metastasis , Patient Compliance , Pilot Projects , Quality of Life , Treatment Outcome , Walk Test , Walking
19.
Nat Rev Dis Primers ; 5(1): 22, 2019 03 28.
Article in English | MEDLINE | ID: mdl-30923312

ABSTRACT

Lymphoedema is an oedematous condition with a specific and complex tissue biology. In the clinical context of cancer, the pathogenesis of lymphoedema ensues most typically from the modalities employed to stage and treat the cancer (in particular, surgery and radiotherapy). Despite advances in cancer treatment, lifelong lymphoedema (limb swelling and the accompanying chronic inflammatory processes) affects approximately one in seven individuals treated for cancer, although estimates of lymphoedema prevalence following cancer treatment vary widely depending upon the diagnostic criteria used and the duration of follow-up. The natural history of cancer-associated lymphoedema is defined by increasing limb girth, fibrosis, inflammation, abnormal fat deposition and eventual marked cutaneous pathology, which also increases the risk of recurrent skin infections. Lymphoedema can substantially affect the daily quality of life of patients, as, in addition to aesthetic concerns, it can cause discomfort and affect the ability to carry out daily tasks. Clinical diagnosis is dependent on comparison of the affected region with the equivalent region on the unaffected side and, if available, with pre-surgical measurements. Surveillance is indicated in this high-risk population to facilitate disease detection at the early stages, when therapeutic interventions are most effective. Treatment modalities include conservative physical strategies that feature complex decongestive therapy (including compression garments) and intermittent pneumatic compression, as well as an emerging spectrum of surgical interventions, including liposuction for late-stage disease. The future application of pharmacological and microsurgical therapeutics for cancer-associated lymphoedema holds great promise.


Subject(s)
Lymphedema/diagnosis , Lymphedema/etiology , Neoplasms/complications , Cytoreduction Surgical Procedures/methods , Humans , Inflammation/etiology , Lymph Nodes/pathology , Lymph Nodes/surgery , Lymphedema/physiopathology , Mass Screening/methods , Nasal Decongestants/therapeutic use , Neoplasm Staging/methods , Quality of Life/psychology
20.
Lymphat Res Biol ; 17(1): 51-59, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30300090

ABSTRACT

BACKGROUND: Bioimpedance spectroscopy (BIS) is commonly used in the assessment and monitoring of lymphedema. This study investigated electrodes as a source of variability that could impact the accuracy of BIS in the clinic and determined if Ag/AgCl electrocardiograph (ECG) electrodes could be used as an alternative to instrument-specific electrodes. METHODS AND RESULTS: Two types of Ag/AgCl electrodes were studied: instrument-specific bioimpedance electrodes (bioimpedance) and single tab ECG electrodes (cardiac). Six areas of investigation were addressed: intrinsic electrode resistance; electrode age; drive electrode position; electrode width/surface area; concordance between cardiac and bioimpedance electrodes; and mixing electrode types and batches. Participants included women (n = 26) and men (n = 8), both with (n = 4) and without lymphedema (n = 30). Resistance (R0) of the limbs was measured and used to calculate interlimb BIS ratios. Intrinsic electrode resistance varied between batches (p ≤ 0.001), with cardiac electrodes recording higher resistance. Electrode age had no impact on limb resistance (p = 0.85). Drive electrode position biased limb resistance (0.1%-2.3%) and electrode size/surface area had a small (≤1%), but significant effect on limb resistance (p ≤ 0.001). However, calculation of interlimb BIS ratios negated the impact of these as well as any effect of mixing electrode batches and types (p = 0.15-0.96). Electrode type had no impact on arm and leg resistance, or interlimb BIS ratios (p = 0.173-0.289). CONCLUSION: Calculation of interlimb BIS ratios improves accuracy of clinical BIS. Ag/AgCl cardiac electrodes can be used as an alternative to device-specific electrodes to measure limb resistance.


Subject(s)
Body Composition , Dielectric Spectroscopy/instrumentation , Lymphedema/diagnosis , Adult , Arm/physiopathology , Case-Control Studies , Dielectric Spectroscopy/methods , Electric Impedance , Electrocardiography/instrumentation , Electrodes , Female , Humans , Leg/physiopathology , Lymphedema/physiopathology , Male , Middle Aged , Silver/chemistry , Silver Compounds/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...